Homoharringtonine-Based Induction Therapy Reduces the Recurrence Rate of Pediatric Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation

Homoharringtonine-Based Induction Therapy Reduces the Recurrence Rate of Pediatric Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation

Allogeneic hematopoietic stem cell transplantation (HSCT) is an effective treatment for acute myeloid leukemia (AML). Pediatric patients with AML who relapse after HSCT have an extremely poor prognosis. We performed a retrospective study of pediatric patients diagnosed with AML from August 2015 to O...

Full description

Bibliographic Details
Main Authors: Bin Wang, Xiaojia Wen, Ruidong Zhang, Guanghua Zhu, Ying Wu, Yuanyuan Zhang, Wei Lin, Jiaole Yu, Jia Fan, Jing Li, Jun Yang, Maoquan Qin, Huyong Zheng
Format: Article
Language:English
Published: SAGE Publishing 2023-07-01
Series:Cell Transplantation
Online Access:https://doi.org/10.1177/09636897231183559

Internet

https://doi.org/10.1177/09636897231183559

Similar Items